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Interleukin 2 (IL-2) is best characterized as a lymphocyte growth factor . It
induces cell proliferation by virtue of binding to a specific cell surface receptor
that is expressed on activated T and B lymphocytes (1-3) . Previously it has been
shown that the IL-2 receptor (IL-2-R) is present at least in two forms, differing
from each other on the basis of their affinity for ligand, and that IL-2-specific
signals are delivered by the high-affinity IL-2-R (4, 5) . We have demonstrated
that the two forms of the IL-2-R can be reconstituted by expressing the gene
encoding the human p55 (Tac antigen) in a mouse T cell line, EL-4 (6) . Our
study as well as those of others suggest that an additional molecule(s) present in
lymphocytes is required for the formation of the high-affinity IL-2-R (6-10) .
While this work was in progress, several studies have demonstrated the presence
of a cell surface molecule, p75, which is also capable of binding to IL-2, and
indicated that the p75 constitutes the high-affinity IL-2-R in association with p55
(11-14) . In view of those observations, elucidation of the structural basis of the
high-affinity IL-2-R is one of the essential issues in understanding the mechanism
of the IL-2-mediated signal transduction .
In growth factor receptors such as insulin receptor (Ins-R)' (15, 16), epidermal
growth factor receptor (EGF-R) (17) and platelet-derived growth factor receptor
(PDGF-R) (18), the receptor molecules contain a large cytoplasmic domain with
tyrosine kinase activity that seems to play an essential role in the ligand-mediated
signal transduction (19) . In fact, the cytoplasmic domain of EGF-R has been
shown to regulate high-affinity EGF binding of the extracellular domain (20) . In
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contrast to those receptors, the cytoplasmic domain of the human p55, consisting
of only 13 amino acids (21-23), is too small to mediate any enzymatic activity.
However, since amino acid sequences of the membrane-spanning and cytoplasmic
domains are highly conserved between the human and mouse p55 molecules, it
has been suggested that those regions play a role in IL-2-mediated signal
transduction (24, 25). In this regard, our recent expression study using mutant
cDNAs for human p55 showed no evidence for the role of two possible phospho-
rylation sites (Ser-247 and Thr-250) that are present within the cytoplasmic
domain in the structure and function of the high-affinity IL-2-R (26) .
To clarify further whether or not such a small cytoplasmic domain as well as
the transmembrane region of the p55 play any role in IL-2 specific signaling, we
constructed and expressed unique genes, each of which encodes a chimeric
receptor consisting of the p55-derived extracellular domain and Ins-R-derived
transmembrane/cytoplasmic domains (IL-2-R/Ins-R chimera). The structure of
one of the expressed chimeric receptors mimics the kinase-type growth factor
receptor with the ligaed-binding domain being for IL-2 . Here we present results
of the structure and functional properties of the expressed chimeric molecules
and discuss the significance of our findings in the IL-2-mediated signal transduc-
tion.
Materials and Methods
Construction ofExpression Plasmidsfor IL-2-R/Ins-R Chimeric Receptor cDNAs.
￿
Plasmid
constructions were carried out essentially following the general procedures (27).
To clone the cDNA for the human insulin receptor, a cDNA library was prepared from
poly(A)+ RNA of a human B cell line IM9 (28) by the standard procedure (29), and the
library was screened with a synthetic oligonucleotide as the probe. One of the identified
clones, designated pins-R, contained within the cDNA a 1.6 kb Pst I-Pst I fragment
encoding part of the ,# subunit of the human Ins-R (Fig. 1 A) (15, 16). The Pst I fragment
was then cloned into the Pst I site of M13 phage mp10 and the cDNA was excised out of
the vector DNA by Eco RI and Hind III digestion. The resultant Hind III (5')-Eco RI
(3') fragment was further digested by Ssp I, and the 1 .4 kb Ssp I-Eco RI fragment was
isolated (for the location of the unique restriction sites, see Fig. IA) (15, 16). The Bam
HI-Aat II fragment of the human IL-2-R (p55) cDNA (0.8 kb) was isolated from
pSVIL2R-3 (6). In this procedure the Aat II site was rendered flush by T4 DNA
polymerase. Then the 1 .4 kb Ins-R cDNA and the 0.8 kb IL-2-R cDNA fragments were
ligated and cloned into Eco RI-Bam HI-cleaved pUC19 backbone DNA. The resulting
recombinant plasmid was digested by Xba I and a 2.2 kb DNA fragment containing the
hybrid gene was isolated. It was then ligated with the Xba I-digested backbone fragment
of pSVIL2R-3 to obtain pSVILIR-K (Fig. IA). For the construction of pSVILIR-E,
pSVILIR-K was digested with Xho I and subsequently treated by T4 DNA polymerase to
generate flush ends. Then universal translation terminatorsequences (GCTTAATTAAT-
TAAGC) (Pharmacia Fine Chemicals, Piscataway, NJ) were inserted (Fig. IA). The DNA
sequences at the IL-2-R/Ins-Rjunction and at the terminator insertion site were confirmed
by the sequence analysis (30).
Isolation of EL-4 Cell Clones Expressing Chimeric Receptor cDNAs.
￿
Transfection of the
expression plasmids into a mouse T lymphoma line, EL-4, was performed according to
the method described previously (6). Transformants were selected in RPMI 1640 medium
containing mycophenolic acid (4 ag/ml) and xanthine (250 jAg/ml) for 10-14 d. Expression
of the chimeric receptor molecules was examined by staining the cells with anti-Tac
antibody (31), and Tac+ cells were sorted by fluorescence-activated cell sorter (FACS440;364
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FIGURE 1 .
￿
Construction of the IL-2-R/Ins-R chimeric receptor cDNAs . (A) Construction of
the expression vectors for the chimeric receptors. See Materials and Methods for the detailed
procedure . EC, extracellular domain ; TM, transmembrane domain ; CP, cytoplasmic domain ;
TK, tyrosine kinase domain . (B) The schematic view of the IL-2-R, Ins-R, and chimeric
receptors.
Beckton Dickinson Immunocytometry Systems, Mountain View, CA) . Then the sorted
cells were cloned by seeding into each well of 96-well flat-bottom plates .
Immunoprecipitation . Immunoprecipitation was performed as described previously
(32) . Briefly, cells (5 x 10') were first suspended in 1 ml PBS containing 20 mM glucose .
After addition of 10 gl of lactoperoxidase solution (2 mg/ml), 20 ul of glucose oxidase
solution (10 U/ml) and I Il of Na 1211 (0.5 mCi), the enzyme reaction was continued for
30 min at room temperature . Subsequently, the cells were washed five times with PBS
containing 1 mM PMSF and lysed in the cell extraction buffer (10 mM Tris HCl, pH 7.5 ;
0.5% NP-40 ; 0.15 M NaCl ; 1 mM PMSF) . The cell lysate was preabsorbed sequentially
with BSA-coupled Sepharose 4 B and protein A-coupled Sepharose 4 B (Pharmacia Fine
Chemicals) . The preabsorbed lysate was incubated overnight with protein A-coupled
Sepharose 4 B and 10 ug/ml anti-Tac . Subsequently, the beads were extensively washed
as described by Wano et al . (32), and boiled for 5 min in the SDS sample buffer. The
supernatant was then subjected to SDS-PAGE analysis . SDS-PAGE standards (Bio-Rad
Laboratories, Richmond, CA) were run in parallel as size markers .
Purification of IL-2-R/Ins-R Chimeric Receptor.
￿
The chimeric receptor was purifiedHATAKEYAMA ET AL.
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according to the method described by Roth et al. (33). Briefly, cells (7.6 X 109) expressing
chimeric receptor molecules were washed twice with PBS and lysed in the cell extraction
buffer (5 X 10' cells/ml) for 60 min on ice. The lysate was centrifuged at 16,000 g for 30
min. After preabsorption with BSA-Sepharose column, the supernatant was applied on
the anti-Tac Sepharose 4 B column. The column was washed with 10 mM Tris HCl, pH
7.4, 0.5% NP-40, 0.5 M NaCl. Materials were eluted with 0.12 M borate buffer, pH 6.5,
0 .1 % NP-40, 1 .5 M MgC12, and immediately diluted with about five volumes of 50 mM
Tris HCl (pH 7.5). The material was first dialyzed against 50 mM Tris HCl (pH 7.5) and
then concentrated by ultrafiltration (Centricon; Milipore, Bedford, MA).
IL-2 BindingAssay.
￿
Labeling of recombinant IL-2 (5 X 10' U/mg protein) and the IL-
2 binding assay were carried out according to methods described previously (6). Briefly,
cellswere incubated with serial dilutions of radioiodinated human recombinant IL-2 (2.4
X 104 cpm/ng protein) in a total volume of 500 ul of RPMI 1640 containing I % BSA,
0.1% NaN3, and 25 mM Hepes (pH 7.4). After 30 min incubation at 37°C, cells were
layered onto an oil cushion consisting of 80% di-n-butyl phthalate and 20% olive oil, and
cell-bound and free IL-2 were separated by centrifugation. The tips of the tubes that
contained cell pellets were cut and the remaining radioactivity was determined. Nonspe-
cific binding was estimated by adding a 250-fold excess of unlabeled IL-2 in the binding
assay.
Effect ofIL-2 on Growth ofEL-4 Transformants.
￿
Cells (2 X 10') were seeded into each
well of 96-well microculture plates and were cultured in RPMI 1640 medium supple-
mented with 10% FCS in the presence or absence of various concentrations of human
recombinant IL-2 for 72 h. Subsequently, cells were pulsed with [sH]thymidine (1 'Ci/
well) for 4 h and the [6H]thymidine uptake was measured. The effect of IL-2 was
demonstrated by stimulation index as previously described (6).
IL-2 Internalization Assay. IL-2 internalization was examined by using a method
described previously (34). Briefly, cells (4 X 106 cells/0.5 ml) were incubated with 500
pM 1251-IL-2 for 30 min at 0 ° C. Incubation was continued at either 0°C or 37°C for
another 30 min. Then equal volumes (0.5 ml) of PBS or 0.5 M acetic acid, pH 2.2, 0.5 M
NaCl was added to the cell suspension and cells were immediately centrifuged through a
150 WI oil cushion. The tips of each tube were cut and the radioactivity was determined.
Nonspecific binding level was determined by performing the assay in the presence of 200-
fold excess of unlabeled IL-2. Specific binding level was determined by subtracting the
nonspecific binding level.
In Vivo Phosphorylation of Chimeric Receptor.
￿
Cells (2 X 10') were washed with phos-
phate-free MEM and incubated in the phosphate-free-MEM supplemented with 10%
dialyzed FCS for 30 min at 37 °C. Then cells were resuspended in the same medium and
incubated for 2 h at 37'C in the presence of 1 MCi/ml [32P]orthophosphate . Cells were
then washed twice with PBS containing 1 mM PMSF, 5 mM EDTA, 10 mM Na4P207
(PPi), and 2 mM NaV04, and lysed in a lysate buffer (10 mM Tris HCI, pH 7.4; 0.5%
NP-40; 1 mM PMSF; 5 mM EDTA; 10 mM PPi; 2 mM NaV04). After immunoprecipi-
tation by anti-Tac, the receptor was analyzed by 10% SDS-PAGE.
In Vitro Phosphorylation by Chimeric Receptor.
￿
10 ng of the purified chimeric receptor
molecule was incubated at 25° C for 1 h in 50 mM Tris HCI, pH 7 .5, 0.1% NP-40 in the
presence or absence of human recombinant IL-2. Autophosphorylation reaction was
carried out in 30 q1 reaction mixture containing
,y_[32P]ATP
(1 'M) and MnC12 (2 mM)
at 25°C for 1 h. For exogenous substrate phosphorylation, casein was added to the same
reaction mixture at a final concentration of 1 .5 mg/ml. The sample was then analyzed by
10 or 15% SDS-PAGE.
Results
Construction and Expression of Genes Encoding Chimeric Receptors.
￿
Expression
plasmids encoding IL-2-R (p55)/Ins-R chimeric receptors were constructed as
illustrated in Fig. 1 . In one of those chimeric receptors, the p55 protein was366
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FIGURE 2.
￿
Expression of Tac epitope in the EL-
4 transformant clones. Each transformant clone
wasstained with anti-Tac as the primary antibody
and FITC-conjugated goat anti-mouse IgG (Cap-
pel Laboratories, Cochranville, PA) as the second
antibody. Clones ILIR-2, ILIR-9, and ILIR-10
were established by transfecting pSVILIR-K, and
ST-6, by pSVILIR-E. Dotted lines represent fluo-
rescence pattern of cells treated with second-step
antibody alone.
attached at residue 210 to the 0 subunit of the human Ins-R at residue 927, so
that the extracellular domain of p55 is fused to the membrane-spanning and
entire cytoplasmic region ofthe Ins-R (plasmid pSVILIR-K). A truncated version
ofthis receptor was generated by introducing a universal translation terminator
into the Xho I site located near the beginning of the kinase domain of Ins-R
(plasmid pSVILIR-E). The cytoplasmic tail of the truncated form consists of 42
amino acid residues that contain a new Ala residue at the carboxyl terminus.
Therefore, it is devoid of the tyrosine kinase domain. The predicted molecular
sizes of the IL-2-R/Ins-R chimeric receptor proteins are 72 kD for pSVILIR-K
and 31 kD for pSVILIR-E.
Transfection of the expression plasmids into mouse T cell line EL-4 was
carried out by the bacterial protoplast fusion method as described previously (6),
and the transformants were selected for mycophenolic acid (MPA) resistance.
We then obtained MPA-resistant, stable EL-4 transformant clones that constitu-
tively express the Tac epitope on the cell surface (Fig. 2). The clones, ILIR-2,
ILIR-9, and ILIR-10 were obtained by transfection with pSVILIR-K, whereas
clone ST-6 was obtained by transfecting pSVILIR-E. To examine whether or
not the transformants express the chimeric molecules, cells were externally
labeled with '251 and the cell lysates were immunoprecipitated with anti-Tac
antibody (31). As shown in Fig. 3, a 95-100 kD species was detected on the
surface of ILIR-2, ILIR-9, and ILIR-10 cellsand 55-60 kD specieswere detected
oncells expressing either native p55 (ELT-5) (6) orthe chimeric receptor without
the tyrosine kinase domain (ST-6). While the observed molecular masses are 25-
30 kD larger than those predicted from the protein sequence, it is most likely
that posttranslational modification accounts for the difference, since massive
glycosylation is known to occur in p55 processing (35).
IL-2 Binding Activity ofIL-2-R/Ins-R Chimeric Molecules Expressed on EL-4.
￿
We
next examined the IL-2 binding activity of the chimeric receptor by using
radiolabeled human recombinant IL-2. Scatchard plot analysis of the IL-24000
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FIGURE 3 .
￿
Immunoprecipitation ofthe native and chi-
meric IL-2-R moleculesbyanti-Tac antibody . Cellswere
membrane-labeled with 1251 by lactoperoxidase method .
Cell lysates were prepared, subjected to immunoprecip-
itation by anti-Tac and precipitated molecules were
analyzed on a 10% SDS-PAGE as described in Materials
and Methods : Lane 1, ELT-5 (an EL-4 transformant
expressing the native p55 [61; 2, ILIR-2; 3, ILIR-10; 4,
ILIR-9 ; 5, ST-6 . Arrows indicate positions ofsize mark-
ers (kD) .
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Scatchard analysis of
1251-IL-2 binding assay in EL-4
transformants. The number of
high- and low-affinity IL-2-R was
estimated by computer-assisted
analysis of the two linear compo-
nents of the Scatchard plots . For
the experimental details, see Ma-
terials and Methods .
binding data gave evidence of two classes of binding sites in transformant clones
expressing IL-2-R/Ins-R chimeric molecules either with or without the kinase
domain (Fig . 4) . The dissociation constants (Kd) of the high- and low-affinity IL-
2 binding sites were 110-240 pM and 6-10 nM, respectively, and the receptor
numbers were ^"900-1,500 and 6,000-12,000 per cell, respectively . The com-
parable affinities and densities on the EL-4 cells transfected with native p55
cDNA are 160-220 pM and 3,000-4,500 per cell, and 2.1-2.2 nM and 6,000-
7,500 per cell for high- and low-affinity sites, respectively (6) . Transfection and
expression of the same chimeric receptor cDNAs in mouseL cells resulted in the
appearance only of low-affinity IL-2-R (results not shown) . MPA-resistant clones368
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Effect of human recombinant IL-2 on the growth
of EL-4 transformants . Each of the EL-4 transformants (2 x
10') was grown in RPMI 1640 containing 10% FCS and
indicated concentrations of human recombinant IL-2 for 72
h, then pulsed with ['H]thymidine for another 4 h and the
['H]thymidine uptake wasmeasured . ILIR-2 (-----), ILIR-9 ( .
. .), ILIR-10 (-), ST-6 (- - - -) . ST-2(---- ) is anMPA-
resistant EL-4 transformant clone that does not express Tac
epitope on the cell surface . Result was demonstrated by stim-
ulation index, which was calculated as follows: ['H]thymidine
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that do not express the Tac epitope, as well as parental EL-4 cells showed no
significant IL-2 binding (data not shown) .
Effect of IL-2 on Growth of EL-4 Transformants Expressing Chimeric Recep-
tors . We have shown previously that EL-4 transformants expressing the native
human p55 on their cell surface respond to human IL-2 (6) . In those cells, IL-2
delivered negative growth signals through the reconstituted high-affinity IL-2-
R. The p55 molecule was also shown to deliver positive growth signals when it
was expressed in an IL-2-dependent mouse T cell clone (9) . As demonstrated in
Fig . 5, the growth of EL-4 transformants expressing the chimeric receptors was
inhibited by IL-2 . The inhibitory effect was detectable at the IL-2 concentration
of 10 U/ml (^-13 pM), indicating that the signaling occurs via the high-affinity
receptor . The inhibitory effect was completely abolished by the addition of 1
wg/ml anti-Tac antibody, which inhibits binding of IL-2 to human IL-2-R, while
addition of the same amount of anti-mouse IL-2-R (AMT-13), which inhibits
the binding of IL-2 to mouse IL-2-R (36), had no effect (Fig. 6) .
Ligand-mediated Internalization of Chimeric Receptor Molecules.
￿
It has been
shown that IL-2 molecules bound to the high-affinity IL-2-R are selectively
internalized (34, 37) . To determine whether or not the internalization of IL-2
occurs via the chimeric receptor molecules, an acid-wash method described by
Weissman et al . (34) was applied . Cells were incubated with '251-IL-2 (500 pM)
at 0 or 37'C . Subsequently, the acid-resistant, cell-bound radioactivity was
determined to measure the degree of the IL-2 internalization. Like the EL-4
cells expressing the native human p55, the EL-4 transformants expressing
chimeric receptors either with or without the kinase domain mediated the IL-2
internalization at 37°C (Fig . 7) .
Protein Kinase Activity ofIL-2-R/Ins-R Chimeric Molecule.
￿
Native insulin recep-
tor has been shown to undergo insulin-mediated autophosphorylation both in
vivo and in vitro (38-40) . We therefore examined in vivo phosphorylation of
the chimeric receptor molecule possessing the tyrosine kinase domain . Cells
(ILIR-2) expressing the chimeric receptor were incubated for 2 h with [32p]_
orthophosphate, lysed, and the receptor was immunoprecipitated by anti-Tac .
As shown in Fig . 8A, a predominant band of 95-100 kD was detected by
autoradiography, indicating that the chimeric receptor molecule is phosphoryl-
ated . However, this in vivo phosphorylation level was not altered by the additionFIGURE 6 .
￿
Effect of human and mouse anti-IL-2-R antibody on the cell growth inhibition by
human IL-2 . Each of the EL-4 transformants was cocultured for 72 h with the agents as
described below, and thymidine uptake was measured . Agents used were: 1, none ; 2, human
recombinant IL-2 (h-rIL-2) 100 U/ml ; 3, anti-Tac (10,ug/ml) ; 4, anti-Tac (1 ag/ml) ; 5, h-rlL-
2 (100 U/ml)and anti-Tac (10 ug/ml) ; 6, h-rIL-2 (100 U/ml)and anti-Tac (1 Ag/ml) ; 7, AMT-
13 (10 Ag/ml) ; 8, AMT-13 (1 ug/ml) ; 9, h-rIL-2 (100 U/ml) and AMT-13 (10,ug/ml) ; 10, h-
HL-2 (100 U/ml) and AMT-13 (1 wg/ml) .
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s0
0
HATAKEYAMA ET AL .
￿
369
FIGURE 7 . Chimeric receptor-mediated IL-2 internaliza-
tion . The specific binding was measured as described in Ma-
terials and Methods . 100% activity represents a total IL-2
bound at 0 or 37 °C, which is obtained by washing cells with
PBS. Solid bars show specific IL-2 internalizations at 0°C, and
open bars show specific IL-2 internalizations at 37°C. No
specific binding was observed when parental EL-4 cells were
used in this assay (<50 cpm per 4 X 106 cells) .
of IL-2, anti-Tac or 12-o-tetradecanoylphorbol-13-acetate (TPA) (data not
shown) . To determine ifthe chimeric receptor still possessesautophosphorylation
activity, the molecule was purified by anti-Tac immunoaffinity chromatography
and subsequently incubated in the presence of y-[32P]ATP and MnC12 . The
result shown in Fig . 8B demonstrates that the 95-100 kD affinity-purified
receptor manifests autophosphorylating kinase activity . The phosphorylation
seems to be tyrosine-specific, as the phosphorylated residues were resistant to
treatment with KOH (data not shown) . The receptor-associated kinase also had
an ability to phosphorylate an exogenous substrate, casein (Fig . 8C) . Although
we do not at present have direct evidence that the purified chimeric receptor370
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FIGURE 8 .
￿
In vivo and in vitro phosphorylation of the chimeric receptor molecules . (A) Cells
(ILIR-2) were labeled with [s2P]orthophosphate for 2 h at 37°C . Receptor molecules were
solubilized and immunoprecipitated with anti-Tac (lane 2) or control mouse monoclonal
antibody (lane 1) and analyzed by 10% SDS-PAGE . (B) Affinity-purified chimeric receptor
molecule of 95-100 kD was analyzed for its specific autophosphorylation activity in the
presence (lanes 2-5) or absence (lane 1) of MnC12 . Samples were pretreated with IL-2 for I h
at 25°C, and the phosphorylation reactions were carried out by adding .y-["P]ATP and were
analyzed by 10% SDS-PAGE . The position of the chimeric receptor molecule of 95-100 kD
is indicated by an arrow : Lanes 1 and 2, no IL-2 added ; 3, 100pM IL-2 ; 4, 10 nM IL-2 ; 5, 1
pM IL-2 . (C) Auto-and exogenous substrate phosphorylations were measured by adding casein
as a substrate for tyrosine kinase in the autophosphorylation assay as described in B . The
reaction mixture was analyzed by 15% SDS-PAGE. Lane 1, no IL-2 added; 2, 1 jUM IL-2 .
Arrow indicates the position of phosphorylated casein .
still retains IL-2 binding activity, the kinase activity was neither enhanced nor
suppressed by the addition of IL-2 in vitro at concentrations up to I jM (Fig . 8
B) .
Discussion
To gain insight of the structural nature of IL-2-R and the signal transduction
mechanism operating in the IL-2/IL-2-R system, we have constructed two genes
each encoding an extracellular human IL-2-R (p55 or Tac antigen) domain fused
to transmembrane and cytoplasmic domains of the human Ins-R with or without
a tyrosine kinase domain . When transfected into mouse T lymphoma EL-4 cells,
both genesdirected the expression of chimeric receptor molecules, which specif-
ically bound IL-2, underwent internalization, and mediated IL-2-specific inhibi-
tion of cell growth in a manner indistinguishable from the native p55 . Cells
transfected with the chimeric receptor cDNA manifested both high- and low-
affinity IL-2 binding sites, and theKd values were comparable to those of native
p55 expressed on EL-4 (6) .
Comparison of the human and mouse p55 cDNAs has revealed the conserva-HATAKEYAMA ET AL.
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tion of the amino acid sequences in the transmembrane and cytoplasmic domains
between the two species, suggesting that those regions may have important roles
forsignal transduction by the IL-2-R (24, 25). Our results, however, demonstrate
that both transmembrane and cytoplasmic domains of the human p55 can be
replaced with that of a heterologous receptor to reconstitute the functional high-
affinity IL-2-R . Because the amino acid sequences of the transmembrane and
cytoplasmicdomains of human p55 and human Ins-R do not show any significant
homology, it seems quite unlikely that the region derived from Ins-R mimics the
correspondingregion of p55. Therefore, the amino acid conservation may reflect
other roles, such as regulation of synthesis or degradation, or subtle forms of
signaling not measured in these experiments. It may be worth noting that we
could not observe any significant differences in their property as IL-2-R between
the receptor molecules with or without the Ins-R-derived kinase domain. This
indicates the existence of a large cytoplasmic domain with active kinase does not
affect the IL-2-R structure and function to a detectable degree.
Previously, we as well as others have presented evidence for a lymphocyte-
specific molecules(s) whose interaction with p55 creates the high-affinity IL-2-R
(6-10). In view of the finding presented here, such a molecule(s) would have
direct or indirect interactions with p55 outside the cell. The primary structure
of the extracellular domain of the chimeric receptor molecule is slightly shorter
(six amino acids) than that of native p55, but this difference does not impair the
formation of a functional IL-2-R complex. While this work was in progress,
existence of a 75 kD membrane protein (p75) that might be involved in the
formation of the high-affinity human IL-2-R was reported (11-14). p75 by itself
binds IL-2 with intermediate affinity (Kd, 1 nM) (12-14). If p75 is the p55-
associated molecule we mentioned above, then the high-affinity IL-2-R expressed
on the EL-4 transformants should be composed of human p55 and mouse p75.
Our recent affinity crosslink studies with 1251-IL-2 support this idea; i.e., 125I-IL-
2 was crosslinked to a mouse p75 protein in the cells expressing native or
chimeric receptors (data not shown). The formation of such a receptor complex
can explain why chimeric receptor molecules that do not use the transmembrane
and cytoplasmic domains of p55 can transduce an IL-2-specific signal. It seems
likely that p75 is primarily responsible for the IL-2-specific signal transduction,
and that the role of p55 is to increase the affinity of p75 for IL-2. The Kd values
of the high-affinity IL-2-R expressed on EL-4 transformants are slightly higher
than those expressed on human T lymphocytes (50-80 pM in our experimental
condition, result not shown). This observation implies that binding of mouse p75
to human IL-2 is weaker than that of human p75 to human IL-2. From this
viewpoint, it is worth noting that we were unable to crosslink the human IL-2 to
any surface molecule on EL-4 parental cells, suggesting that the mouse p75 has
very low if any affinity to the human IL-2 (our unpublished data).
Insulin stimulates the tyrosine kinase activity of Ins-R and potentiates the
autophosphorylation of the ,Q subunit of the receptor molecule (38-40). In
contrast, the kinase activity of the chimeric receptor was not modulated by IL-2
binding inasmuch as measured by receptor autophosphorylation in vitro. No
significant increase in cellular glucose uptake or amino acid uptake was observed37 2
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after treatment of EL-4 transformants with IL-2 (results not shown). The
chimeric receptor thus appears incapable of converting an IL-2 signal into an
insulin-specific cellular action .
The results presented here further emphasize the notion that the signal
transduction mechanism operating in the IL-2/IL-2-R system is quite unique as
compared to other growth factor receptors. Elucidation of the molecular nature
of the component(s) other than p55 that would constitute the high-affinity IL-2-
R in association with p55 will uncover the novel features concerning the ligand
affinity and signal transduction in the IL-2/IL-2-R system.
Summary
Chimeric genes were constructed which gave rise to the expression of novel
receptor molecules consisting of the extracellular domain of the human interleu-
kin 2 receptor (IL-2-R; p55 or Tac antigen)joined to the transmembrane domain
and either full-length or truncated cytoplasmic domain of the human insulin
receptor (Ins-R). Expression studies using mouse T cell line EL-4 revealed that
the chimeric receptors are able to manifest properties indistinguishable from the
authentic IL-2-R. On the other hand, stimulation of the tyrosine kinase activity
by IL-2 was not observed in the chimeric receptor with the entire cytoplasmic
domain of the Ins-R. These findings thus shed light on the structural confor-
mation and functioning of the IL-2-R. complex .
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